Quantum Genesis AI Corp. cash flow statement QGAI

In fiscal 2025, which ended Jul 31, 2025, Quantum Genesis AI Corp. used $125,181 of cash from operations.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Apr 30, 2026
FY 2025
Jul 31, 2025
FY 2018
Jul 31, 2018
FY 2017
Jul 31, 2017
Operating
Depreciation and amortization
—
—
0
-25.0%
0
Operating cash flow
-0
-0
-0
+92.8%
-0
Investing
Capital expenditures
—
—
0
—
Financing
Financing cash flow
0
0
—
0
Change in cash
Free cash flow
—
—
-0
—
Ratios
Free cash flow margin
—
—
-15.65%
—
Capital expenditures to revenue
—
—
12.72%
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Industrial Organic Chemicals (SIC 2860)
Listed as
QGAI (OTC)
Fiscal year ends
July 31
Incorporated in
NV
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1663038
Former names
Quantumzyme Corp. (until Feb 13, 2026); Reliant Service Inc (until Mar 13, 2023)

Other Industrial Organic Chemicals companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.